Endometriosis Market by Product Type, Distribution Channel, End User 2024-2032

1
Global Endometriosis Market Research and Forecast
Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Endometriosis Market Global Industry
  Trends, Share, Size, Growth, Opportunity and
  Forecast 2024-2032," the global endometriosis
  market size reached US 2.4 Billion in 2023.
• Endometriosis refers to a medical condition that
  causes excessive growth of endometrial tissues in
  various regions outside the uterus, such as the
  fallopian tube, uterine cavity, and ovaries.
  Chronic pelvic pain, fatigue, bloating,
  constipation, infertility, and discomfort during
  urination are some of the common symptoms.
• It is diagnosed through physical examinations of
  the pelvic region and various imaging tests, such
  as ultrasound and magnetic resonance imaging
  (MRI). Endometriosis is treated using
  over-the-counter medications, fertility
  treatments, hormonal therapy, and surgical
  procedures. These treatments aid in alleviating
  pain, increasing the chance of pregnancy,
  minimizing complications, improving the overall
  quality of life, and managing various symptoms,
  such as inflammation, nausea, and scarring.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/endometriosis-market/re
  questsample

4
Report Description

• Global Endometriosis Market Trends
• The rising prevalence of endometriosis due to
  genetics, hormonal imbalance, retrograde
  mensuration, immune system dysfunction, and
  environmental toxins is one of the primary
  factors driving the market growth. In addition to
  this, the increasing awareness among the masses
  regarding early diagnosis of endometriosis to
  prevent various complications, such as ovarian
  cysts, adhesion, and bladder dysfunction, is
  acting as another growth-inducing factor.
  Furthermore, rising demand for minimally invasive
  (MI) surgical procedures, such as laparoscopy,
  which reduces pain and scarring, promote faster
  recovery, and minimize the risk of infections,
  blood loss, and surgical complications, is
  providing an impetus to the market growth.
  Additionally, the recent development of
  non-surgical treatment options, such as
  ultrasound therapy which utilizes high-intensity
  focused ultrasound (HIFU) to destroy endometrial
  tissues at high precision and eliminate the need
  for medications and hormonal treatments, is
  positively influencing the market growth.
  Moreover, growing initiatives by several
  governments and international organizations, such
  as the Endometriosis Association and World
  Endometrial Society, to increase awareness and
  improve access to care for women are creating a
  positive outlook for market growth. Other
  factors, including rising healthcare expenditure,
  rapid advancements in diagnostic techniques, and
  increasing investment in the research and
  development (RD) of novel treatment methods, are
  anticipated to drive the market growth.
• Looking forward, the market is expected to reach
  US 3.7 Billion by 2032, exhibiting a CAGR of
  4.71 during 2024-2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/endometriosis-market

5
Report Segmentation

• Breakup by Type
• Superficial Peritoneal Lesion
• Endometrioma
• Deeply Infiltrating Endometriosis
• Others
•  
• Breakup by Diagnosis and Treatment
• Diagnosis
• Ultrasound
• Pelvic Exam
• Laparoscopy
• Magnetic Resonance Imaging (MRI)
• Hysteroscopy
• Sonohysterography
• Treatment
• Hormonal Therapy

6
Report Segmentation

• Pain Management
• Conservative Surgery
• Breakup by End Users
• Hospitals
• Homecare
• Speciality Centers
• Others
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Abbott Laboratories
• AbbVie Inc.
• Bayer AG
• Debiopharm Group
• Gedeon Richter Plc
• Kissei Pharmaceutical Co. Ltd.
• Myovant Sciences GmbH
• Sanofi S.A.
• Teva Pharmaceutical Industries Ltd.

8
Key Questions Answered in the Report
9
Key Questions Answered in the Report
10
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Endometriosis
  Market    5.1    Market Overview    5.2  
   Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Type    6.1   
  Superficial Peritoneal Lesion        6.1.1
  Market Trends        6.1.2 Market Forecast   
  6.2    Endometrioma        6.2.1 Market Trends 
        6.2.2 Market Forecast    6.3    Deeply
  Infiltrating Endometriosis        6.3.1 Market
  Trends        6.3.2 Market Forecast       

11
Table of Contents

•     6.4    Others        6.4.1 Market Trends   
      6.4.2 Market Forecast7    Market Breakup by
  Diagnosis Treatment    7.1    Diagnosis     
    7.1.1 Market Trends        7.1.2 Key
  Segments           7.1.2.1 Ultrasound         
   7.1.2.2 Pelvic Exam           7.1.2.3
  Laparoscopy           7.1.2.4 Magnetic Resonance
  Imaging (MRI)           7.1.2.5 Hysteroscopy   
         7.1.2.6 Sonohysterography        7.1.3
  Market Forecast    7.2    Treatment       
  7.2.1 Market Trends        7.2.2 Key Segments 
           7.2.2.1 Hormonal Therapy         
   7.2.2.2 Pain Management           7.2.2.3
  Conservative Surgery        7.2.3 Market
  Forecast8    Market Breakup by End Users   
  8.1    Hospitals        8.1.1 Market Trends   
      8.1.2 Market Forecast    8.2    Homecare   
      8.2.1 Market Trends        8.2.2 Market
  Forecast
• For more information, visit https//www.imarcgrou
  p.com/endometriosis-market/toc

12
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

13
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com